Literature DB >> 3816175

MULTI-FORTE, a microcomputer program for modelling and simulation of pharmacokinetic data.

D W Bourne.   

Abstract

MULTI-FORTE is an expanded version of the MULTI non-linear fitting programs written by Yamaoka et al. The functions of the three original programs (including Gauss-Newton and Simplex fitting algorithms) have been combined and translated into FORTRAN 77 on the Macintosh computer for both speed and convenience. Models can be described in integrated equation form or as a system of differential equations. Bayesian estimation is also available. Improved numerical integration routines have been added including methods suitable for systems of 'stiff' differential equations (Fehlberg's 4/5 Runge-Kutta method and Gear's DIFSUB subroutine). MULTI-FORTE is a user-friendly program taking data from keyboard or disk file to produce output on screen, printer, or disk file in tables or printer-type plots.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816175     DOI: 10.1016/0169-2607(86)90062-3

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  5 in total

1.  Lack of effect of short-term passive smoking on the metabolic disposition of theophylline.

Authors:  D T Casto; B M Schnapf; M A Clotz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.

Authors:  B K Wagner; D A O'Hara
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

3.  The Pharmacokinetics of Single Dose vs Steady-State Doses of Propranolol in Cirrhotic Malay Patients.

Authors:  R Zain-Hamid; Z Ismail; S Mahendra Raj; I L Shuaib; S S J Mohsin
Journal:  Malays J Med Sci       Date:  2002-01

4.  The pharmacokinetics of amiloride-hydrochlorothiazide combination in the young and elderly.

Authors:  Z Ismail; E J Triggs; B A Smithurst; W Parke
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability.

Authors:  Julian Nomme; Zheng Li; Raymond M Gipson; Jue Wang; Amanda L Armijo; Thuc Le; Soumya Poddar; Tony Smith; Bernard D Santarsiero; Hien-Anh Nguyen; Johannes Czernin; Anastassia N Alexandrova; Michael E Jung; Caius G Radu; Arnon Lavie
Journal:  J Med Chem       Date:  2014-11-07       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.